Researchers have warned that a dangerous monkeypox variant with a fatality rate as high as 10% is circulating in Central Africa, which could trigger new global outbreaks.
After analyzing 1,463 cases between 2013 and 2017, scientists have found that monkeypox transmission in a remote part of the Democratic Republic of the Congo is much higher than previously thought.
In an effort to prevent bioterrorism attacks, just in case, SIGA Technologies Inc (NASDAQ: SIGA) started working on the smallpox treatment, Tpoxx, after the 9/11 terrorist attack that shook the world. FDA approved Tpoxx for smallpox in 2018.
Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments.
The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care and biotech stocks on the move.